RE2 Awarded $2.7 Million Contract to Develop Underwater Dexterous Manipulation System for EOD Applications

RE2, Inc., a leading developer of mobile manipulation systems, announced today that the company was awarded a $2.7 Million contract by the Office of Naval Research to develop an Underwater Dexterous Manipulation System for Explosive Ordnance Disposal (EOD) Applications (DMEA).

RE2's DMEA technology will provide EOD personnel with the ability to remotely and effectively address Waterborne Improvised Explosive Devices (WIEDs).

"We are honored that ONR chose RE2 to develop a strong, highly dexterous underwater manipulation system," stated Jorgen Pedersen, president and CEO of RE2. "We thrive on complex engineering challenges and are excited to leverage our mobile manipulation expertise for the underwater systems market."

WIEDs pose a significant threat to our vessels, bridges, and ports. WIEDs placed in congested areas, such as bridge pilings, are particularly difficult to access and defeat. RE2's dual-arm dexterous manipulation technology integrated onto an Unmanned Underwater Vehicle (UUV) will make it possible to perform EOD tasks in confined spaces.

Pedersen continued, "We are working with several unmanned underwater systems subject matter experts, including Bluefin Robotics, The Pennsylvania State University Applied Research Lab, SPAWAR Systems Center Pacific, and Dr. Hagen Schempf, to ensure the success of the technology and program."

About RE2 Robotics
RE2 Robotics is developing the next generation of mobile robotics technologies that enable your robot to better interact with the world. RE2's research efforts focus on creating interoperable manipulation systems with human-like performance, intuitive human robot interfaces, and advanced autonomy software for mobile robotics. For more information, please visit www.resquared.com or call 412.681.6382 FREE.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.